acquired resistance to new tb drugs: insights for ... · acquired resistance to new tb drugs:...
TRANSCRIPT
![Page 1: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/1.jpg)
Acquired Resistance to New TB Drugs:
Insights for Diagnostics and
Treatment
Sébastien Gagneux, PhD
CPTR Workshop
Washington DC, 4th - 7th April 2016
Dept. of Medical Parasitology & Infection BiologyTuberculosis Research Unit
![Page 2: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/2.jpg)
Case Study From Switzerland
• Tibetan refugee (HIV-neg., HBV-pos.)
• Primary resistance to:
1. isoniazid2. rifampicin (+ compensatory mutation in rpoC)3. pyrazinamid4. streptomycin5. ethionomide6. fluoroquinolones7. linezolid (!)
→ Primary preXDR-TB
![Page 3: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/3.jpg)
“Clinical Cure” Relaps
Bloemberg et al. 2015 NEJM 373: 1986-8
Resistance
mutations
to 7 drugs
![Page 4: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/4.jpg)
“Clinical Cure” Relaps
bedaquilineR
clofazimineR
Bloemberg et al. 2015 NEJM 373: 1986-8
![Page 5: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/5.jpg)
“Clinical Cure” Relaps
capreomycinR
bedaquilineR
clofazimineR
Bloemberg et al. 2015 NEJM 373: 1986-8
![Page 6: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/6.jpg)
“Clinical Cure” Relaps
capreomycinR
bedaquilineR
clofazimineR
Bloemberg et al. 2015 NEJM 373: 1986-8
![Page 7: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/7.jpg)
“Clinical Cure” Relaps
delamanidR
capreomycinR
bedaquilineR
clofazimineR
Bloemberg et al. 2015 NEJM 373: 1986-8
![Page 8: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/8.jpg)
“Clinical Cure” Relaps
bedaquilineR
clofazimineR
capreomycinR
delamanidR
Bloemberg et al. 2015 NEJM 373: 1986-8
![Page 9: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/9.jpg)
Treatment History
Bloemberg et al. 2015 NEJM 373: 1986-8
![Page 10: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/10.jpg)
We Need More Research On:
• Within-host dynamics
→ Acquisition of MDR-TB
→ Diagnostics / Treatment
• Between-host dynamics
→ Transmission of MDR-TB
→ Surveillance
![Page 11: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/11.jpg)
A Web of Epistasis Mediates MDR in Mtb
Trauner et al. Drugs 2014 74: 1063-72
![Page 12: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/12.jpg)
Positive Sign Epistasis in DoubleR
Borrell et al. Evolution Med Publ Health 2013 eot003: 65-74
rpoB / gyrA mutations
![Page 13: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/13.jpg)
Mutational Pathway in M. tuberculosis
MDR
(rpoB)
XDR
(gyrA)
G88CG88C
wtwt
H526RH526R
D94GD94G
D94ND94NG88CG88C
H526PH526P
D94GD94G
D94ND94N D94YD94Y
H526YH526Y
D94ND94N
D94GD94G
D94YD94Y
G88CG88C
S531LS531L
D94GD94G
D94ND94N
D94YD94Y
S531WS531W
D94GD94G
D94YD94Y
G88CG88CG88CG88C
wtwt
H526RH526R
D94GD94G
D94ND94NG88CG88C
H526PH526P
D94GD94G
D94ND94N D94YD94Y
H526YH526Y
D94ND94N
D94GD94G
D94YD94Y
G88CG88C
S531LS531L
D94GD94G
D94ND94N
D94YD94Y
S531WS531W
D94GD94G
D94YD94Y
G88CG88C
0.80-0.98
< 0.80
> 0.99
Re
lati
ve
Fit
ne
ss
Borrell et al. Evolution Med Publ Health 2013 eot003: 65-74
![Page 14: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/14.jpg)
0
10
20
30
40
50
60
70
80
D94G D94N D94Y G88C
gyrA mutations
Fre
qu
en
cy
D516V D516S S531L L533P
GyrA Mutations in Clinical XDR-TB (N=89)
Borrell et al. Evolution Med Publ Health 2013 eot003: 65-74
rpoB mutation:
![Page 15: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/15.jpg)
A case for
Personalized
Medicine (?)
Muller et al. 2013 Trends Genet 29: 160-9
![Page 16: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/16.jpg)
Conclusions
• New TB drugs can be “lost” quickly
• Intra- and inter-host bacterial dynamics ???
• Role of epistasis ???
• Host factors need to be considered
→ Need Research in Biology and Epidemiology !!!
![Page 17: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/17.jpg)
Thanks to…
Collaborators:
• Douglas Young - NMIR• Iñaki Comas - UV• Joel Ernst – NYU• Rob Wilkinson – UCT• Rob Warren - SU• Matthias Egger –UBE• Erik Böttger - UZH• Midori Kato-Maeda - UCSF• Simon Harris - WTSI• Moses Joloba – MU• Dorothy Yeboah-Manu - NMIMR
• Bouke de Jong – ITM• Ruedi Aebersold – ETHZ• Uwe Sauer – ETHZ• Tanja Stadler – ETHZ• Jörg Stelling – ETHZ• Christian Beisel - ETHZ• Qian Gao – FU• Stefan Niemann - RCB• Johannes Krause – UT• Abraham Aseffa - AHRI
![Page 18: Acquired Resistance to New TB Drugs: Insights for ... · Acquired Resistance to New TB Drugs: Insights for Diagnostics and Treatment Sébastien Gagneux, PhD CPTR Workshop Washington](https://reader030.vdocuments.site/reader030/viewer/2022040812/5e552e776667d8705118358e/html5/thumbnails/18.jpg)
Thanks to…
• Sonia Borrell• Lukas Fenner• Mireia Coscolla• Daniela Brites• Andrej Trauner• Levan Jugheli• Julia Feldmann• Miriam Reinhard• Sebastian Gygli• Liliana Ruthaiwa• Rhastin Castro• Francis Mhimbira• Chloe Loiseau